Evidence map›Paper›PMID 21354322›Full record

ArticleComparative biochemistry and physiology. Part B, Biochemistry & molecular biology2011

Catalytic and inhibitor binding properties of zebrafish monoamine oxidase (zMAO): comparisons with human MAO A and MAO B.

Milagros Aldeco, Betül Kacar Arslan, Dale E Edmondson

Erratum issuedAbstract readComparative Study
In one paragraph

Article in Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Molecular psychiatry of zebrafish.Molecular psychiatry · 2015
    Article
  9. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Milagros AldecoDepartment of Biochemistry and Chemistry, Emory University, Atlanta, GA 30322, USA.
Betül Kacar Arslan
Dale E Edmondson
Emory University · US

Funding

COVALENT FLAVIN COENZYMES IN FLAVOENZYME CATALYSISR01GM029433 · NIGMS · EMORY UNIVERSITY · PI EDMONDSON, DALE E. · 1985 to 2013
$4.6M
NIGMS NIH HHS GM-29433NIGMS NIH HHS R01 GM029433
6 · The paper itself

Abstract

A comparative investigation of substrate specificity and inhibitor binding properties of recombinant zebrafish (Danio rerio) monoamine oxidase (zMAO) with those of recombinant human monoamine oxidases A and B (hMAO A and hMAO B) is presented. zMAO oxidizes the neurotransmitter amines (serotonin, dopamine and tyramine) with k(cat) values that exceed those of hMAO A or of hMAO B. The enzyme is competitively inhibited by hMAO A selective reversible inhibitors with the exception of d-amphetamine where uncompetitive inhibition is exhibited. The enzyme is unreactive with most MAO B-specific reversible inhibitors with the exception of chlorostyrylcaffeine. zMAO catalyzes the oxidation of para-substituted benzylamine analogs exhibiting (D)k(cat) and (D)(k(cat)/K(m)) values ranging from 2 to 8. Structure-activity correlations show a dependence of log k(cat) with the electronic factor σ(p) with a ρ value of +1.55±0.34; a value close to that for hMAO A but not with MAO B. zMAO differs from hMAO A or hMAO B in benzylamine analog binding correlations where an electronic effect (ρ=+1.29±0.31) is observed. These data demonstrate zMAO exhibits functional properties similar to hMAO A as well as exhibits its own unique behavior. These results should be useful for studies of MAO function in zebrafish models of human disease states.

Indexed as

AnimalsBenzylaminesBinding SitesBiocatalysisDextroamphetamineDopamineGene ExpressionHumansIsoenzymesKineticsMonoamine OxidaseMonoamine Oxidase InhibitorsOxidation-ReductionPichiaProtein BindingRecombinant ProteinsBenzylaminesDextroamphetamineDopamineIsoenzymesMonoamine OxidaseMonoamine Oxidase InhibitorsRecombinant ProteinsSerotoninTyramine

Identifiers

PMID21354322
PMCPMC3071876
OpenAlexW2033954733

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.